---
tags:
  - iints/source
  - iints/source/pharmacology
source_id: "klaff_2020_urli_pkpd"
source_bucket: "packaged_evidence"
category: "pharmacology"
component: "insulin_action_profiles"
url: "https://doi.org/10.1111/dom.14049"
doi: "10.1111/dom.14049"
status: active
---

# Ultra Rapid Lispro Demonstrates Accelerated Pharmacokinetics and Pharmacodynamics

> [!info] What this source supports
> Reference for ultra-rapid insulin variants and action-curve configuration.

| Field | Value |
| --- | --- |
| Source ID | `klaff_2020_urli_pkpd` |
| Bucket | `packaged_evidence` |
| Category | `pharmacology` |
| SDK component | `insulin_action_profiles` |
| DOI | 10.1111/dom.14049 |
| URL | https://doi.org/10.1111/dom.14049 |
| Origin file | `src/iints/presets/evidence_sources.yaml` |

## Citation

Klaff LJ, et al. Diabetes Obes Metab. 2020;22(10):1799-1807.

## User Interpretation

Use this source to explain **why the SDK default, metric, dataset, or hardware-safety boundary exists**. It is evidence support for pre-clinical simulation and documentation, not a medical approval claim.
